Strikingly, C9orf72 expansion in patients dying with ALS predisposed the frontal cortex to elevated co‐expressed markers of neuroinflammation, the same ones co‐expressed in a concerted increased pattern across FTD and ALS/FTD patients. Here, C9orf72 is linked to amyotrophic lateral sclerosis.